Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Gel 1% for Knee Osteoarthritis
NCT00426621Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Diclofenac Sodium Gel with Placebo (2 arms). Primary endpoints: WOMAC pain index at 12 weeks, WOMAC function index at 12 weeks and 1 more. Started Nov 2006; status: completed.
02
Drugs
diclofenac sodium
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00426621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426621.